Hynes Keller & Hernandez, LLC Announces Investigation of Tetraphase Pharmaceuticals Inc. (TTPH)

NEW YORK, June 23, 2016 /PRNewswire/ -- Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors of Tetraphase Pharmaceuticals Inc. ("Tetraphase" or the "Company") (NASDAQ: TTPH) concerning possible breaches of fiduciary duty arising from alleged false and misleading statements about the efficacy and potential for its drug Eravacycline to achieve approval by the FDA.

Click here for more information about our investigation of TTPH:
http://hkh-lawfirm.com/investigations-cases/tetraphase-pharmaceuticals-inc-ttph/

Hynes Keller & Hernandez, LLC is a national law firm that represents institutional and individual investors.  The firm is focused on providing exemplary legal services in the area of shareholder litigation. The firm has an experienced litigation team which has achieved significant victories on behalf of the firm's clients.  You can visit our website at www.hkh-lawfirm.com for more information.  Attorney advertising. Prior results do not guarantee similar outcomes.

If you hold shares in TTPH and would like to obtain additional information about your legal rights and protect your investment, please visit our website or contact the attorneys below.  There is no cost or obligation to you. 

Contact:

SOURCE Hynes Keller & Hernandez, LLC

Related Links

http://www.hkh-lawfirm.com